Activation of N-methyl-D-aspartate receptors in the feline retrorubral nucleus elicits orofacial dyskinesia

European Journal of Pharmacology

Volumn 349, Issue 1, 1998, Pages 23-31

  Arts, Monique ^a   Bemelmans, Frank ^a   Cools, Alexander ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

(Cat); Caudate nucleus; Dopamine; NMDA (N methyl D aspartate); Orofacial dyskinesia; Retrorubral nucleus

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CAT; CAUDATE NUCLEUS; DOSE RESPONSE; DRUG RECEPTOR BINDING; MALE; NONHUMAN; OROFACIAL DYSKINESIA; PRIORITY JOURNAL;

ANIMALS; CATECHOLAMINES; CATS; CAUDATE NUCLEUS; DOPAMINE AGONISTS; DYSKINESIA, DRUG-INDUCED; EAR; EXCITATORY AMINO ACID AGONISTS; IMIDAZOLINES; MALE; N-METHYLASPARTATE; RECEPTORS, N-METHYL-D-ASPARTATE; RED NUCLEUS; TONGUE;

EID: 0032524593     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00167-8     Document Type: Article

References (27)

1. Arts, M.P.M., Bemelmans, F.F.J., Cools, A.R., 1998. Role of the retrorubral nucleus in striatally elicited orofacial dyskinesia in cats: effects of muscimol and bicuculline. Psychopharmacology, in press.
2. 3H] dopamine release from mesencephalic cell cultures Eur. J. Pharmacol. 264:1994;361-369.
3. Cools A.R. Mesolimbic system and tardive dyskinesia: new perspectives for therapy. Mod. Probl. Pharmacopsychol. 21:1983;111-123.
4. Cools A.R., van Rossum J.M. Excitation-mediating and inhibition mediating dopamine receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and chemical data. Psychopharmacologia. 45:1976;243-254.
5. Cools A.R., Struyker Boudier H.A.J., van Rossum J.M. Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain. Eur. J. Pharmacol. 37:1976;283-293.
6. Cools A.R., van Dongen P.A.M., Janssen H.J., Megens A. Functional antagonism between dopamine and noradrenaline within the caudate nucleus of cats: a phenomena of rhythmically changing susceptibility. Psychopharmacology. 59:1978;231-242.
7. Cools A.R., Ellenbroek B., van den Bos R., Gelissen M. Mesolimbic noradrenaline: specificity, stability and dose-dependency of individual-specific responses to mesolimbic injections to alpha-noradrenergic receptor agonists. Behav. Brain Res. 25:1987;49-61.
8. Cools A.R., Spooren W., Bezemer R., Cuypers E., Jaspers R., Groenewegen H.J. Anatomical distinct output channels of the caudate nucleus and oro-facial dyskinesia: critical role of the sub-commissural part of the globus pallidus in oral dyskinesia. Neuroscience. 33:1989;535-542.
9. Cools, A.R., Spooren, W., Cuypers, E., Bezemer, R., Jaspers, R., 1989. Heterogeneous role of neostriatal and mesostriatal pathology in disorders of movement: a review and new facts. In: Crossman, A.R., Sambrook, M.A. (Eds.), Neural Mechanisms in Disorders of Movement. John Libbey, London, pp. 111-119.
10. Ellison G., See R.E. Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia. Psychopharmacology. 98:1989;564-566.
11. Grace A.A., Bunny B.S. The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4:1984;2866-2876.
12. Jenner P., Marsden C.D. Is the dopamine hypothesis of tardive dyskinesia completely wrong? Trends Neurosci. 9:1986;259.
13. Jeste D.V., Caligiuri M.P. Tardive dyskinesia. Schizophr. Bull. 19:1993;303-315.
14. Jiménez-Castellanos J., Graybiel A.M. Subdivision of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience. 23:1987;223-242.
15. Klawans H.L., Goetz C.G., Perlik S. Tardive dyskinesia: review and update. Am. J. Psychiatry. 137:1980;900-908.
16. Kornhuber J., Kim J.S., Kornhuber M.E., Kornhuber H.H. The corticonigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res. 322:1984;124-126.
17. Sakai S.T. Corticonigral projections from area 6 in the raccoon. Exp. Brain Res. 73:1988;498-504.
18. Sigwald J., Boutier D., Courvoisier S., Piot P. Quatre cas de dyskinesia facio-buccu-linguo-mastcatrice a evolution prolongee secondaire a un traitement neuroleptique. Rev. Neurol. 100:1959;751-755.
19. Snider, R.S., Niemer, W.T., 1964. A Stereotaxic Atlas of the Cat Brain. The Univ. of Chicago Press, Chicago.
20. Spooren W.P.J.M., Cuypers E., Cools A.R. Oro-facial dyskinesia and the sub-commissural part of the globus pallidus in cat: role of acetylcholine and its interaction with GABA. Psychopharmacology. 99:1989;381-385.
21. Spooren W.P.J.M., Groenewegen H.J., Cools A.R. Subregions of the caudate nucleus and their in- and output channels in oro-facial dyskinesia. Brain Res. 539:1991;85-93.
22. Spooren W.P.J.M., Piosik P.A., Cools A.R. Dopamine D1 receptors in the sub-commissural part of the globus pallidus and their role in oro-facial dyskinesia in cats. Eur. J. Pharmacol. 204:1991;217-222.
23. Spooren W.P.J.M., Veening J.G., Cools A.R. Descending connections of the sub-pallidal area in the cat: projections to the subthalamic nucleus, the hypothalamus, and the midbrain. Synapse. 15:1993;104-123.
24. Struyker Boudier H., Teppema L., Cools A.R., van Rossum J.M. (3,4-dihydroxyphenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition. J. Pharm. Pharmacol. 27:1975;882-883.
25. Waddington J.L. Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and conflict of paradigms. Int. Rev. Neurobiol. 31:1989;297-353.
26. Waddington J.L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology. 101:1990;431-447.
27. Westerink B.H.C., Santiago M., de Vries J.B. The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Arch. Pharmacol. 345:1992;523-529.